Upcoming Symposia
5th Annual Neuro-Oncology Symposium 2022
Enabling Technologies for Brain Tumor Care
Saturday, May 21st, 2022
According to the National Brain Tumor Society, an estimated 700,000 people in the United States are living with a primary brain tumor, and approximately 88,970 more will be diagnosed in 2022. Treatment and surgical options in brain tumor care continue to evolve as new technologies emerge as well as new ways of thinking which lead to shifts in how brain tumor care is provided. This course will review progress, updates, and breakthroughs that enable the technologies available in treating brain tumors.
5th Annual Cerebrovascular Symposium 2022
Innovations in the Management of Complex Cerebrovascular Disease
Thursday, August 25th, 2022
Register Here
According to the CDC, cerebrovascular disease is the most common life-threatening neurological event in the United States, with stroke being one of the leading causes of serious long-term disability. An estimated 30,000 people experience a ruptured cerebral aneurysm, and arteriovenous malformations (AVMS) present in about 1 percent of the general population. Risk of complications from unique cerebrovascular diseases, like arteriovenous fistula (DAVF) and mycotic aneurysms, can be decreased by transdisciplinary training to recognize emergent cases, understand possible interventions, and refer care.
Past Keynotes:
- 2021: Lucas Elijovich, MD
- 2020: Postponed
- 2019: Eric Peterson, MD
- 2018: Adam Arthur, MD, MPH
- 2017: Robert F. James IV, MD, FAANS